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Summary Objectives: To evaluate primary care physicians’ knowledge of guidelines
for the management of COPD.
Method: Survey to 455 primary care physicians in private practice in the state of
Geneva, Switzerland, and to 243 physicians practicing in Geneva University Hospital.
Results: Although 75% of respondents identified that the prevalence of COPD was
increasing and 33% recognized it as a major public health issue, only 55% of
physicians used spirometric criteria to define COPD, and one-third knew the correct
GOLD criteria. Fifty-two percent felt uncomfortable with smoking cessation
counselling. Sixty-two percent administered influenza vaccination annually and
29% had immunized their patients against Pneumococcus. Beta2-agonists were the
first-line treatment for 89% of physicians, but 10% overestimated their clinical
benefit. Twenty-five percent of respondents used systematically inhaled corticoster-
oids, but 46% ignored their indications. Oral corticosteroids were used by 42% of
physicians outside of acute exacerbations. Seventy-nine percent thought that oral
steroids had a beneficial effect on stable COPD. Finally, pulmonary rehabilitation
was underused by 72% of physicians.
Conclusions: This study shows major gaps in the knowledge of all core elements of
guidelines for the management of COPD and identifies targets for future educational
programs.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Chronic obstructive pulmonary disease (COPD) is a
leading cause of morbidity, mortality and disability
worldwide and represents a huge economical burden
for the healthcare system.1,2 Major efforts have
been made in order to produce evidence-based
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clinical practice guidelines to help physicians diag-
nose and manage patients with COPD.3–6
Although these guidelines are widely available,
evidence suggests that COPD remains an under-
diagnosed disease, especially in early stages, which
can have a negative impact on the benefit of
therapeutic interventions. In addition, patients
hospitalised for COPD have a high incidence of
modifiable risk factors suggesting unsatisfactory
management.7
We aimed to explore the knowledge of primary
care physicians about current guidelines for the
management of COPD and to identify parameters
that could benefit from educational interventions.
Methods
Study design
This is a prospective observational cross-sectional
study using a mailed anonymous self-administered
survey targeting primary care physicians in the
state of Geneva, Switzerland. The questionnaire
was designed in order to explore the most relevant
items of current clinical recommendations. It was
elaborated following the GOLD initiative8 and the
Swiss Respiratory Society guidelines.9 The Swiss
Respiratory Society guidelines follow strictly the
GOLD guidelines and use the same criteria for
assessment and treatment of patients with COPD.
Survey questions focused on four core elements
of the guidelines: (1) epidemiology and identifica-
tion of risk factors for COPD, (2) diagnostic criteria
and procedures, (3) patient education and pre-
ventive measures, (4) treatment knowledge and
practice. It was developed and validated by two
senior general internal medicine physicians and by
one senior lung disease specialist.
There were 39 multiple choice questions: 10
questions on epidemiology and preventive mea-
sures (prevalence, importance of the problem, risk
factors, influenza and pneumococcal vaccines), six
on diagnosis (role of spirometry, spirometric criter-
ia to define and grade the severity of COPD), seven
on physicians’ knowledge of the potential benefit
of therapeutic interventions (benefit on symptoms,
quality of life, life expectancy of bronchodilata-
tors, steroids, rehabilitation, smoking cessation or
oxygen), and 16 on physicians’ prescription
habits (proportion of patients receiving specific
treatments: short or long-acting bronchodilatators,
steroids). The last section of the survey per-
tained to physician practice characteristics and
educational background (solo vs. group practice,
number of patients with COPD seen every month,
access to spirometry, board certification (Table 1)).
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Table 1 Physician and practice characteristics.
Demographic variable Private practice Hospital practice Totaln
Sex
Female 49 (26%) 52 (43%) 101 (32%)
Male 141 (74%) 70 (57%) 212 (68%)
Age (median, range) 50, 30–73 33, 25–57 45, 25–73
Number of patients with COPD seen every month
0–5 116 (62%) 50 (42%) 166 (54%)
6–10 27 (14%) 31 (26%) 58 (19%)
11–20 33 (18%) 32 (28%) 65 (21%)
421–50 12 (6%) 5 (4%) 17 (6%)
Type of practice
Individual 110 (58%) NA
Group 81 (42%) NA
Board certification
Community and family medicine 44 (23%) 3 (2%) 47 (15%)
General internal medicine 122 (64%) 48 (40%) 170 (54%)
None 24 (13%) NA
In training NA 71 (58%)
Access to spirometry 88 (47%) 117 (96%) 205 (66%)
nThe total does not always sum up to 315 (total of responders) due to the omission of few questions by some physicians.
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The survey and a cover letter was mailed to 455
primary care physicians. These were identified
through the local medical association (Geneva
Medical Association) register. In our health care
system and in the urban environment of Geneva
three groups of physicians are identified as primary
care physicians. First, board certified general
internal medicine physicians have a 5-year training,
in general, internal medicine and are the primary
care physician of a majority of people living in the
state of Geneva. Second, board certified commu-
nity and family physicians follow a 5-year curricu-
lum including at least 2 years of general internal
medicine. Both board certifications are delivered
by the Swiss Medical Association. Finally, a small
proportion of primary care physicians work as
general practitioners without board certification
from the Swiss Medical Association but are accre-
dited by the State Medical Association.
The survey was also mailed to 243 residents,
fellows and staff physicians practicing in the
Departments of Internal Medicine, Community
Medicine, and Geriatrics of Geneva University
Hospital. This hospital is a 1110 beds primary and
tertiary care teaching hospital.
Non-responders were sent a second mailing 3
months after the first. A prepaid return envelope
was included.
Data analysis
Data were analysed using SPSS 11.0 (SPSS Inc.,
Chicago, IL).
Results
After two mailings, 45% (315/698) of the ques-
tionnaires were returned. The response rate was
42% (193/455) for physicians in private practice,
and 50% (122/243) among hospital practicing
physicians. Physicians’ characteristics of both
groups are summarized in Table 1.
Epidemiology and risk factors
Seventy-five percent of the responders consider
that the prevalence of COPD is increasing and one-
third recognize that it is a major public health issue
(COPD is currently the fourth cause of death
worldwide and prevalence and mortality are
projected to increase during the next decades).
Unanimously (98%), physicians identify cigarette
smoking as the most important risk factor for the
disease.
Diagnostic procedures and criteria
Although GOLD guidelines define spirometry as the
gold standard for diagnosis, only 82% of respon-
dents consider spirometry as the most appropriate
test when a diagnosis of COPD is suspected (Table
2). In addition, only 55% use explicit spirometric
criteria to define COPD and only one-third know the
correct diagnostic criteria according to GOLD
(FEV1/FVCo70%) (Table 2). When asked which
spirometric threshold values should be used to
define severe COPD, only 19% of respondents
identify the correct criteria (FEV1o50%).
Patient education and preventive measures
Although 92% of physicians regularly discuss smok-
ing cessation with their patients, more than half
(52%) feel uncomfortable with smoking cessation
counselling. In addition, 22% do not recognize that
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Table 2 Diagnostic procedure and criteria used to define COPD.
First choice exam used by survey respondents in order to confirm a suspected diagnosis of COPD
(% of respondents)
Spirometry 82%
Chest X-ray 3%
Arterial blood gas 4%
Physical exam 11%
Diagnostic criteria used to define COPD (% of respondents)
Clinical criteria only 41%
Spirometric criteria 55%
Knowledge of GOLD spirometric criteria 33%
Knowledge of GOLD criteria defining severe COPD 19%
Chest X-ray 2%
Arterial blood gas 2%
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smoking cessation has a favourable impact on life
expectancy and on disease progression.
Although influenza vaccine can reduce serious
illness and death by about 50% in patients with
COPD, only 62% of physicians administer influenza
vaccination annually to their patients with moder-
ate COPD and 71% to patients with severe COPD.
Reported immunization rates against pneumococcal
infections are 29% and 47% for patients with
moderate and severe COPD, respectively.
Treatment practice and knowledge
Short or long acting beta2-agonists bronchodilata-
tors are the first-line treatment for 26% and 53% of
physicians, respectively. Forty-one percent of
respondents systematically combine beta2-agonists
with anticholinergic agents when treating patients
with severe COPD. Despite this wide use which is
concordant with the guidelines, 18% of physicians
ignore the benefit of bronchodilatators on quality
of life and 10% overestimate their impact on life
expectancy.
Twenty-five percent of physicians prescribe in-
haled corticosteroids systematically to their pa-
tients with severe COPD, but 46% ignore the
accepted indications for their use (COPD patients
with FEV1o50% and repeated exacerbations). In
addition, 15% think that inhaled steroids have a
positive impact on life expectancy which has never
been demonstrated.
Although long-term treatment with oral corti-
costeroids is not recommended in GOLD and may be
harmful, they are used by 42% of the responders
outside of acute exacerbations, and 79% of physi-
cians estimate that oral steroids may have a
beneficial effect on stable COPD.
Finally, pulmonary rehabilitation is underused
despite its benefits on exercise tolerance and
symptoms of dyspnoea and fatigue. Seventy-two
percent of respondents never refer their patients
with moderate COPD to rehabilitation programs.
For patients with severe COPD, rehabilitation is
never used by 38% of the physicians.
Discussion
This study reports primary care physicians’ knowl-
edge of the core element of recent guidelines for
the management of COPD and their self-reported
practice with COPD patients. In spite of the wide
dissemination of international and national guide-
lines, this survey suggests that primary care
physicians practicing in the state of Geneva do
not know the core elements of these guidelines and
that their clinical practice is not in agreement with
current recommendations. Although physicians
recognize the importance of the problem, most of
them do not use the recommended preventive
measures (immunization, smoking cessation coun-
selling), feel uncomfortable with counselling, do
not know the diagnostic criteria for COPD, and
poorly recognize the indications and the benefits of
the treatments they give to their patients. In
particular, they clearly underuse rehabilitation
programs and overuse oral steroids outside of acute
exacerbations. There was no difference between
general internal medicine and community and
family medicine specialists, between physicians in
private vs. hospital practice, or between board-
certified physicians vs. those in training. This lack
of difference may be explained by very similar
training and continuous medical education across
physicians. The large majority of general internists
and community physicians practicing in Geneva
were educated in the same medical school and
were residents in the same hospital (Geneva
University Hospital). Similarly, continuous medical
education rounds are usually organized and fol-
lowed by both groups together.
Although several studies have explored the
impact of guidelines on clinical practice and the
adherence of practitioners to these recommenda-
tions,10–12 only few have explored these aspects for
patients suffering from COPD.13 Our study is in
accordance with data collected from the 1996
National Ambulatory Care Survey (a survey of
office-based visits in the United States) showing
that patients with COPD do not receive optimal
care,14 but adds clues as to why physicians do not
use adequately recommended diagnostic and ther-
apeutic interventions. It identifies gaps in physi-
cians’ knowledge that are potential targets for
future educational efforts.
As with most surveys, the main weakness of this
study is the generalizability and the reliability of
physicians’ responses. They may be affected by
various parameters. First, this is a self-reported
survey. Although the questionnaire was anonymous,
responders may be tempted to idealize their
practice. A prospective chart review could be a
better way to confirm the reported gaps between
recommendations and current practice. Second, it
is impossible to rule out selection bias and to know
whether responders differ from non-responders.
One may suggest that responders are more con-
cerned about COPD care and that the survey
underestimates the misknowledge of current guide-
lines. The response rate (45%) is in the lower range
of what is expected for this type of survey.
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Different hypothesis may be formulated to explain
this low response rate. Our questionnaire was
pretty long and required about 15min to be
completed which was a major obstacle for the
non-responders who expressed why they did not
return the survey. In addition, physicians are not
used in Switzerland to be surveyed about their
clinical practice. Therefore, our questionnaire may
have been perceived as too intrusive.
Various factors may explain why adherence to
clinical practice guidelines and management of
COPD are still suboptimal.15 When questioned
about the gap between guidelines and their clinical
practice, physicians point out that guidelines are
frequently formulated as state-of-the-art reviews
without clear-cut recommendations. In addition,
physicians may rely on their own interpretation of
the medical literature, on recommendations of
local colleagues and on their own experience.16
Physicians need simple, patient-specific and
user-friendly guidelines, which is rarely the
case.17 Finally, effective guidelines should be
compatible with current values and not too
controversial.18
This study provides a strong incentive for the
development of tailored educational efforts in
order to increase physician adherence to current
clinical guidelines. As passive dissemination of
information is generally ineffective in altering
clinical practice, the educational strategy should
include at least one of the following interventions
(shown to be effective): educational outreach
visits, combinations of audit and feedback, remin-
ders, local consensus processes, and interactive
educational meetings.19 These strategies fit with
primary care physicians’ expectations for more
education, both for them and their patients, and
for increased availability of simplified and clearer
guidelines.10
Our study also underscores the gap that may exist
between guidelines dissemination and implementa-
tion. Guidelines are usually produced by experts
after a thorough literature review and are dis-
seminated through medical journals and educa-
tional rounds. Erroneously, guidelines conceivers
may consider that implementation will follow
dissemination. In fact, the development and pub-
lication of a guideline does not ensure by itself
changes in practice patterns.20–22 Therefore, the
next logical step should be to devise a systematic
plan for implementation of these guidelines and the
development of performance measures. GOLD
guidelines were widely disseminated through dif-
ferent channels (web, medical journals, medical
associations, patients associations). Similarly, the
Swiss guidelines were mainly disseminated through
publication in the Journal of the Swiss Medical
Association and in other local medical journals.
These guidelines were also widely presented in
local and national scientific meetings. Despite
these efforts for dissemination, neither a plan for
implementation nor performance measures were
developed.
In conclusion, despite widely disseminated evi-
dence-based clinical practice guidelines, current
knowledge of primary care physicians and out-
patient medical management of patients with
COPD remain suboptimal. The impact of educa-
tional programs on primary care practice should be
evaluated, and performance measures should be
implemented.
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